Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-28
DOI
10.1038/srep14517
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BEVACIZUMAB VERSUS RANIBIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2015) Guohai Chen et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Genetic predictive biomarkers of anti-VEGF treatment response in patients with neovascular age-related macular degeneration
- (2015) Sascha Fauser et al. SURVEY OF OPHTHALMOLOGY
- Predicting Non-response to Ranibizumab in Patients with Neovascular Age-related Macular Degeneration
- (2014) Freekje van Asten et al. OPHTHALMIC EPIDEMIOLOGY
- Complement and autoimmunity
- (2013) Eleonora Ballanti et al. IMMUNOLOGIC RESEARCH
- Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT)
- (2013) Stephanie A. Hagstrom et al. OPHTHALMOLOGY
- INTERLEUKIN 8 PROMOTER POLYMORPHISM PREDICTS THE INITIAL RESPONSE TO BEVACIZUMAB TREATMENT FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
- (2013) Asta Hautamäki et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- GENETIC FACTORS ASSOCIATED WITH RESPONSE TO INTRAVITREAL RANIBIZUMAB IN KOREAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
- (2013) Un Chul Park et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Pharmacogenetics of the Treatment Response of Age-Related Macular Degeneration with Ranibizumab and Bevacizumab
- (2013) Justin Kanoff et al. Seminars in Ophthalmology
- Factors Associated With the Response of Age-Related Macular Degeneration to Intravitreal Ranibizumab Treatment
- (2012) Kenji Yamashiro et al. AMERICAN JOURNAL OF OPHTHALMOLOGY
- Cumulative Effect of Risk Alleles in CFH, ARMS2, and VEGFA on the Response to Ranibizumab Treatment in Age-related Macular Degeneration
- (2012) Dzenita Smailhodzic et al. OPHTHALMOLOGY
- Impact of Loading Phase, Initial Response and CFH Genotype on the Long-Term Outcome of Treatment for Neovascular Age-Related Macular Degeneration
- (2012) Moreno Menghini et al. PLoS One
- Association between Variant Y402H in Age-Related Macular Degeneration (AMD) Susceptibility Gene CFH and Treatment Response of AMD: A Meta-Analysis
- (2012) Han Chen et al. PLoS One
- Complement factor H Y402H gene polymorphism and response to intravitreal bevacizumab in exudative age-related macular degeneration
- (2011) Christian Nischler et al. ACTA OPHTHALMOLOGICA
- CFH,VEGFandHTRA1promoter genotype may influence the response to intravitreal ranibizumab therapy for neovascular age-related macular degeneration
- (2011) Martin McKibbin et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- ASSOCIATION BETWEEN HIGH-RISK DISEASE LOCI AND RESPONSE TO ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT FOR WET AGE-RELATED MACULAR DEGENERATION
- (2011) Anton Orlin et al. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES
- Response to Ranibizumab Therapy in Neovascular AMD – An Evaluation of Good and Bad Responders
- (2010) M. Menghini et al. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE
- Complement Factor H Y402H Variant and Risk of Age-Related Macular Degeneration in Asians: A Systematic Review and Meta-Analysis
- (2010) Naoshi Kondo et al. OPHTHALMOLOGY
- The spectrum of phenotypes caused by variants in the CFH gene
- (2009) Camiel J.F. Boon et al. MOLECULAR IMMUNOLOGY
- Pharmacogenetics of complement factor H (Y402H) and treatment of exudative age-related macular degeneration with ranibizumab
- (2008) A Y Lee et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- Vascular endothelial growth factor in eye disease
- (2008) J.S. Penn et al. PROGRESS IN RETINAL AND EYE RESEARCH
- Molecular pathology of age-related macular degeneration
- (2008) Xiaoyan Ding et al. PROGRESS IN RETINAL AND EYE RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started